CG Oncology, Inc. has grown revenue 345% a year over three years and 345% a year over five. Revenue growth, 3-year annual rate: +345% (Biotechnology median +21%). Revenue growth, 5-year rate: +345%, growth has slowed since the five-year average. Years of annual history on file: 3, FY2023 to FY2025, as filed.

CGONCG Oncology, Inc.

HealthcareUSD

$78.41

$23.9452 weeks$80.66

Is it growing?

Is CGON growing?

CG Oncology, Inc. has grown revenue 345% a year over three years and 345% a year over five.

+345%

Revenue growth, 3-year annual rate · Biotechnology median +21% · compounding fast · compounded from fiscal-year columns as filed

Revenue growth, 5-year rate: +345%
Revenue growth, 5-year rate · +345% over three · growth has slowed since the five-year average
Years of annual history on file: 3
Years of annual history on file · FY2023 to FY2025, as filed

Details›